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The body’s vascular system is thought to have developed in order to supply oxygen and nutrients to cells beyond
the reach of simple diffusion. Hence, relative hypoxia in the growing central nervous system (CNS) is a major
driving force for the ingression and refinement of the complex vascular bed that serves it. However, even before
the establishment of this CNS vascular system, CNS-specific macrophages (microglia) migrate into the brain. Recent
studies in mice point to the fundamental importance of microglia in shaping CNS vasculature during development,
and re-shaping these vessels during pathological insults. In this review, we discuss the origin of CNS microglia and
their localization within the brain based on data obtained in mice. We then review evidence supporting a
functional role of these microglia in developmental angiogenesis. Although pathologic processes such as CNS
ischemia may subvert the developmental functions of microglia/macrophages with significant effects on brain
neo-angiogenesis, we have left this topic to other recent reviews (Nat Rev Immunol 9:259–270, 2009 and Trends
Mol Med 17:743–752, 2011).Microglia – specialized macrophages of the CNS
Microglia are specialized macrophages of the central
nervous system involved in immune regulation, tissue
development, homeostasis and wound repair. Microglia
were first observed by Virchow in the mid-nineteenth
century (see), and described in greater detail by Pio del
Rio-Hortega in 1932. In this almost prescient work, del
Rio-Hortega described microglia morphology, plasticity
during development and with pathological insult, their
cellular origin, and microglia association with white mat-
ter tracts and blood vessels. Despite an immense amount
of research on microglia origin and function since then,
these early views remain surprisingly accurate.Microglia derive from primitive yolk sac macrophages
Microglia belong to the mononuclear phagocytic system -
a family of cells that includes committed precursors in the
bone marrow, circulating blood monocytes and tissue
macrophages in every organ of the body including the
CNS. Mononuclear phagocytes are typified by their ability* Correspondence: christer.betsholtz@ki.se
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distribution, and reproduction in any mediumto ingest large particles; their morphology; their
expression of common surface markers including CD11b,
CD68, Colony Stimulating Factor 1 Receptor (CSF1R),
chemokine receptor CXCR3, and plasma membrane
glycoprotein F4/80 [1]; and their presumed hematopoietic
origin. While microglia certainly meet the functional and
morphological definition of a mononuclear phagocyte
[2-4], their developmental origin has until recently been
less clear.
In mice, hematopoietic stem cells (HSCs) emerge from
the dorsal aorto-gonado-mesonephros (AGM) region 10.5
days after conception (embryonic day (E) 10.5), then mi-
grate to the fetal liver where they expand and differentiate
before definitive hematopoiesis in the spleen and bone
marrow [5-8]. In adult mice, blood monocytes, classical
dendritic cells, and certain tissue macrophages derive
from, and are continuously replaced by, bone marrow-
derived HSCs. It was previously thought that microglia
arose from hematopoietic precursors in two waves of re-
cruitment and differentiation [9,10]. However, it is now
clear, based on evidence from bird, fish and mammals,
that yolk-sac derived macrophage precursors contribute
significantly, if not entirely, to the brain’s microglia. In
avian embryos, analyses using chick-quail transplantation
and parabiosis chimeras show that yolk sac-derived
macrophages migrate to and invade the CNS throughCentral Ltd. This is an Open Access article distributed under the terms of the
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vacularization [11,12]. Subsequent live recordings of cell
movements in zebrafish embryos revealed that yolk
sac-derived macrophages migrate through the cephalic
mesenchyme before its vascularization to reach the brain
pial surface and the roof of the 4th ventricle, from where
they subsequently invade the neuroepithelium and eventu-
ally acquire microglial characteristics [13]. Recently, fate
mapping studies in the mouse using genetic lines such as
Cx3cr1-green fluorescent protein (GFP), Csf1r-GFP, and
cell surface markers, show that microglial precursors ori-
ginate in the yolk-sac, colonize the surface of the brain
between E9.5 and E10.5 (i.e. before the onset of HSC for-
mation in the AGM region), then appear within the brain
neuroepithelium in association with blood vessels by
E10.5 (Figure 1) [14-17]. Lineage analysis with tamoxifen-Pucontrol
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Figure 1 A) Microglia originate from myeloid precursors in the yolk s
with radial glia and with blood vessels (also ingressing into the brain from
in the periventricular vascular plexus (PVP). Arrow indicates progressive dev
[19].) B) Bottom: Reduced vascular branching in the brains of microglia-def
day 12 mice stained for endothelium (CD31, blue) and microglia (F4/80, red
Test P < 0.005.inducible Runx1-CreERtm [14] or Csf1r-CreERtm mice
[15] suggests that the first wave of yolk-sac derived micro-
glia is specified before E8.0. Microglia proliferate through-
out embryogenesis and self-renew without significant
contribution from the bone marrow in the steady state
[14,15,18]. While bone-marrow derived monocytes may
infiltrate the brain parenchyma in conjunction with irradi-
ation or inflammation [19], these cells later disappear, and
do not significantly contribute to the population of resi-
dent microglia [18].
The yolk sac origin of microglia is further supported by
elegant experiments done in mice lacking the transcrip-
tion factors PU.1 [15,20-22] or Myb [15], and in mice with
inactivated Csf1 (CSF1 op/op mice) [23], or Csf1r genes
[24,25]. PU.1 acts in part by activating transcription of


























ac, which migrate into the neuroepithelium by E10. They associate
the pial surface) where they may promote fusion of vascular tip cells
elopment from mouse embryonic day (E) 7 to E10. (Modified from
icient Pu.1−/− mouse embryos. Flat mounted brains from embryonic
). Branch points quantified from 4 mutants and controls. Students T
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[14]. The major ligands of CSF1R, IL34 and CSF1, are
highly expressed in the brain parenchyma during micro-
glial colonization [27]. Mice with genetic deletion of Pu.1
[15] or Csf1r [14] have substantially reduced yolk sac
macrophages and microglia, but normal numbers of circu-
lating monocytes [14,15]. Csf1 op/op mice have a milder
reduction in microglia, consistent with an important role
for IL34 in microglial homeostasis [24,27]. Further work
with Myb-deficient mice clarified the distinct lineage of
microglia. Genetic loss of Myb blocks the generation of
HSCs and their progeny (including circulating monocytes
and granulocytes), but these mice have normal numbers of
tissue macrophages and microglial cells [15]. Similarly,
myeloid-specific expression of diphtheria toxin in LysMCre;
Rosa26DTA transgenic mice eliminates monocyte-derived
macrophages without effect on resident microglia [16].
Taken together, these studies indicate that the large major-
ity of embryonic and adult brain microglia are derived from
early yolk sac precursors.
Patterns of brain colonization by microglia
Once born, yolk-sac derived macrophage precursors mi-
grate into and colonize the whole (mouse) embryo
between E9.5 and E10.5 (Figure 1) [14,15]. The first
organ to be colonized is the brain. Subsequent phases of
microglial brain colonization follow a stereotyped pat-
tern (see [28]). Microglia invade the brain through the
pial surface, then migrate and proliferate, populating the
brain in a dorsal-to-ventral and rostral-to-caudal gradi-
ent. During this time, microglia associate with radial glia
and blood vessels, and are found in close proximity to
dying cells. Eventually, microglia are notably excluded
from the neuroepithelium and cortical plate, and then
are widely distributed in the adult brain, except in areas
of densely packed neuron cell bodies such as the pyram-
idal cell layer. The early association of microglia around
blood vessels has led to the hypothesis that microglia
may enter the brain through the developing vasculature.
Indeed, E10.5 Ncx1−/− embryos [29], which lack heart-
beat and blood flow, are devoid of microglia [14]. How-
ever, it is not clear whether lack of blood flow per se
disrupts brain vascular development in these mutants
(they may lack brain vasculature altogether). It is possible
that some microglia migrate along the abluminal surface
of pial penetrating vessels, independent of blood flow, or
that a small population of microglia (not detected by flow
cytometry in [14] initially invades the brain without con-
tact with vessels [16,30]. Notably, microglia populate the
embryonic retina well before post-natal retinal angiogenesis
occurs [16,31,32], and as mentioned above appear to
colonize zebrafish and chick brains before CNS vascular in-
vasion [11-13]. Shortly after entering the neuroepithelium,
microglia associate with the developing blood vessels in thebrain and retina [11-13,17,33], and microglia and vessels
may therefore directly influence each other’s development,
an idea that lends support from ex vivo studies [32].
Microglia shape the developing CNS vasculature
Because the developing CNS lacks intrinsic vasculature,
CNS blood vessel development occurs exclusively via
angiogenesis [34-36]. Attracted by proangiogenic signals,
new capillaries sprout from perineural vessels, and invade
the neuroectoderm around E10 in mice. These nascent ca-
pillaries are composed of tip cells at the vascular front,
followed by proliferative stalk cells. Tip cells extend filo-
podia toward guidance cues such as VEGF-A. VEGF-A
induces expression of the Notch ligand, Dll4, predomin-
ately in tip cells. Dll4 then activates Notch in adjacent
cells, which down-regulates VEGF receptors and up-
regulates angio-suppressive factors like sFlt1 and Jagged-1,
promoting a stalk cell phenotype (reviewed in [36]). The
interplay between VEGF and Notch signaling is highly
regulated with additional inputs from other major signal-
ing pathways including BMPs [37,38], Semaphorins [39],
and Wnt/βcatenin [40,41]. Additional signaling pathways
that regulate tip cell formation and sprouting include
sphingosine-1-phosphate and its receptor S1pr1 [42-44].
During vascular sprouting, tip cells anastomose with
neighboring tip cells, creating vascular loops. In this way,
vessels sprout, extend, branch and anastomose, iteratively,
toward the center of the neural tube where they establish
a temporary plexus, termed the periventricular vascular
plexus (PVP), around the CNS ventricular spaces and
spinal cord’s central canal [45-47]. As the CNS grows and
differentiates, these vessels associate with microglia,
pericytes, neuroepithelial radial glia and neuroblasts, and
later astrocytes; CNS vessels are refined, arteries and veins
are established, and the mature neurovascular system
takes form.
The retina and optic nerve represent highly specialized
extensions of the forebrain. While its vascularization
occurs by angiogenic sprouting similar to the brain, the
timing and scaffolds that guide angiogenesis are partly
different [48]. During the first week of life, an astrocytic
network arising from the optic nerve invades into the
retina in a centrifugal fashion. As the primitive hyaloid
(hv) vessels that supported the embryonic eye develop-
ment regress, a new primary vascular plexus extends
into the retina, following structural and morphogenic
cues provided by astrocytes and Müller glia. At 7 to 9
days of postnatal life, vessels sprout perpendicularly into
deeper layers of the retina, forming a deep vascular
plexus in the outer plexiform retinal layer (OPL). During
the next 3 weeks, retinal vasculature continues to sprout,
remodel and differentiate into arteries and veins and a
mature neurovascular network is established by 6 weeks
of age.
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As discussed above, microglia migrate into the CNS
and retinal neuroepithelium before vessels do. Microglia
are therefore uniquely positioned to influence the early
sprouting, migration, anastomosis, and refinement of the
growing CNS and retinal vascular systems. Studies of
angiogenesis after microglial depletion, or in mice lacking
microglia, strongly support this concept. Checchin et al.
[49] administered clodronate liposomes either systemically
to deplete macrophages and circulating monocytes, or
intravitreally, which depleted retinal microglia without
reducing circulating monocytes. These authors found that
reducing retinal microglia numbers was associated with a
decrease in retinal vascular density. Selective depletion
of circulating monocytes had no impact on retinal
blood vessels. Importantly, intravitreal co-administration
of microglia with clodronate restored vascularity of the
developing retina, suggesting a microglia-specific effect on
retinal vascular development. Similarly, Kubota et al. [33]
found that Csf1 op/op mice, which initially lack retinal
microglia, have a significant decrease in branching of the
primary vascular plexus. Also, intra-vitreal administration
of CSF1-neutralizing antibodies, or systemic adminis-
tration of a CSF1R kinase inhibitor, decreased microglia
numbers with commensurate reductions in vascular
branching. Branching in these mice recovered as develop-
ment progressed, suggesting that microglia principally
effect developmental vascular remodeling, but do not con-
tribute to maintenance of adult vascular patterns. Interest-
ingly, they found that Csf1 op/op mice, and mice with
pharmacologic microglial depletion, have comparatively
normal numbers of endothelial tip cells and filopodia. This
suggests that microglia facilitate branching anastomosis,
but not tip cell extension. In contrast, Unoki et al [50]
found that depletion of microglia using clodronate
liposomes increased VEGF-mediated neovascular sprouts
in an ex vivo retina culturemodel.
The concept that microglia may act to “bridge” vascu-
lar sprouts during CNS vascular development was
introduced by the work of Fantin et al. [16]. This group
studied vascular ingression and branching in embryonic
hindbrains and retinas of mice lacking macrophages and
microglia (Pu.1−/− and Csf1 op/op mice). In the hind-
brain, microglia numbers were correlated with numbers
of branch points, and were frequently found to be in
contact with neighboring endothelial sprouts. Loss of
microglia was associated with a significant decrease in
the numbers of vascular branch points in the brain peri-
ventricular vascular plexus, without significant effects
on the numbers of tip cells, filopodia, or radial vessels
ingressing from the surface of the brain (see also
Figure 1). Selective depletion of circulating monocytes
using LysmCre;Rosa26DTA transgenic mice did not
affect hindbrain vascular branching, again suggestingthat resident microglia are principally responsible for
facilitated branching. As VEGF is central to tip cell guid-
ance and vascular branching, and VEGF functions as a
macrophage chemoattractant in tumors and in vitro, the
authors evaluated VEGF mRNA levels in the hindbrains
of microglia-deficient embryos and found no difference.
They also analyzed microglia numbers and branching
patterns in mice lacking VEGF, or with selective expres-
sion of VEGF120 (vegfa120/120 mice, which lack heparin
binding VEGF isoforms while retaining the diffusible
VEGF120 isoform). These mutant mice revealed abnor-
malities in hindbrain angiogenesis distinct from those
observed in microglia-deficient mice: vegfa120/120 mice
had more global vascular deficiencies, including decreases
in the numbers of tip cells and penetrating radial vessels,
and vegfa 120/120 and vegfaflox/+;NesCre mice had a more
pronounced reduction in vascular branching than
microglia-deficient mice. Microglia numbers were un-
affected in these VEGF mutants. These results imply that
microglia are not a significant source of VEGF, that VEGF
(unlike CSF1 or IL34) is not a major chemoattractant or
survival cue for microglia, and that the mechanisms of
microglia-facilitated branching may be distinct from, and
complimentary to, VEGF-mediated sprouting.
A recent report from our laboratory confirmed and
extended many of these observations [32]. We found that
microglia-deficient mice (Csf1 op/op mutants and Pu.1
knockouts) had reduced numbers of vascular branch
points in the retina, and that the angle of filopodia
extending from tip cells was reduced in these mice. We
used microglia co-cultured in collagen matrix with mouse
aortic rings to study microglia-vascular interactions more
deeply. These studies revealed an apparent two-way com-
munication between aortic rings and microglia: aortic
rings induced the migration of microglia towards the ring,
while microglia significantly increased vascular branches
emanating from the ring. Interestingly, media from
cultured microglia added separately to cultured aortic
rings had a similar, albeit less potent, effect on vascular
branching. This suggests microglia-blood vessel contact
enhances, but is not necessary to induce branching, and
that microglia may release soluble factors that stimulate
sprouting/branching. Addition of soluble Flt1 (a VEGFR1
ectodomain that traps and neutralizes VEGFA, VEGFB
and, placenta growth factor (PIGF) or VEGFR1 neutral-
izing antibody to microglia-aortic ring cultures did not
effectively inhibit microglia-induced branching,
suggesting that VEGFA and sFlt1 are not major
microglia-derived factors responsible for branching
induction.
In contrast to these findings, Stefater et al. [51] recently
uncovered a mechanism whereby microglia may suppress
angiogenic branching through a Wnt-Flt1 pathway. Here,
they found that microglia associated with the deep retinal
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components including Wnt5a and Wnt11 ligands, and
Wnt receptors Fzd7, Fzd8 and Lrp5. Microglia-specific
haploinsufficiency of the common Wnt-ligand transporter,
Wls (Wlsflox/+;Csf1rCre mice), resulted in increased vascu-
lar branching in the deep vascular plexus. Similarly,
Wnt5a and Wnt11 haploinsufficiency resulted in a similar
phenotype. Interestingly, deletion of Lrp5 from microglia
had the opposite effect, with a significant reduction in
vascular branching. They found that Wnt5a induced
expression of sFlt1, that Wlsflox/+;Csf1rCre mice have
reduced expression of sFlt1, and that microglia-specific
haploinsufficiency of Flt1 phenocopies the Wls and Wnt5a
and Wnt11 mutants. Taken together, their results indicate
that microglia can suppress vascular branching in the deep
retinal vascular plexus by secreting Wnt ligands, which in-
duce, in an autocrine fashion, secretion of the VEGF in-
hibitory protein, sFlt1. These results appear to contrast
with those reported by Fantin et al., who found no differ-
ence in branch density in the deep retinal vascular plexus
in the absence of microglia [13], which they explained was
the net outcome of less branching and less pruning. This
result pinpoints the potential complex role of microglial
cells in retinal angiogenesis, as regulators of endothelial
sprouting, branch fusion and regression.
The feedback loop between VEGF and Notch involves
regulation of both VEGFR-2 and VEGFR-3, although the
individual contribution of each of these VEGF receptors
remains unclear [41,52-54]. The primary ligands for
VEGFR-3, VEGF-C and VEGF-D, are highly expressed
by microglia, and VEGF-C-positive microglia are found
near the fusion points of VEGFR-3-positive vascular
sprouts [54]. While Vegfd knockout mice have no appar-
ent retinal vascular phenotype, Vegfc heterozygous mice
display delayed retinal vascularization and decreased
branching, but increased vessel sprouting and filopodia
[54]. Interestingly, this phenotype is different from mice
with loss of function deletions or antibody blockade of
VEGFR-3 [52,53]. There are alternative explanations for
these discrepancies. One group proposes that VEGFR-3
has both ligand-dependent (and pro-angiogenic) and
ligand-independent (anti-angiogenic) signaling activities
[54]. Another group suggests that ligand-independent
signaling by VEGFR-3 is pro-angiogenic (when Notch
signaling is suppressed) [52]. Further experimentation
should clarify the roles of microglia-derived VEGF-C/D-
VEGFR3 signaling in vascular development.
Other groups have recently explored potential roles for
Notch signaling in microglia-endothelial cell interactions.
Outtz et al. [55] found that Notch signaling is activated in
retinal microglia, which are closely associated with endo-
thelial tip cells expressing the Notch ligand Dll4. More-
over, genetic deletion of Notch1 in retinal microglia led to
a subtle reduction in the numbers of microglia found atthe vascular front. Interestingly, Hoffman et al. [56] found
that the Notch ligand, Jagged1, is highly expressed in peri-
vascular cells of the retina, including microglia. Further
studies should evaluate the specific roles of Notch signal-
ing in microglia, and the impact of this signaling on retinal
vascular development.Outlook
The development of organ-specific vascular beds is de-
pendent upon the close communication between the vas-
cular cells (endothelial cells and mural cells) on the one
hand, and resident cells of the organ, on the other. The
CNS vasculature is in many ways unique in its anatomy
and regulation, and it harbors a highly specific barrier –
the blood–brain, or blood-retina, barrier. The development
of the CNS vasculature hence occurs in tight association
with the development of other components of the CNS,
and as a result of reciprocal communication between the
endothelial cells and different emerging CNS cell types.
This review focuses on the role of microglial cells – a
CNS-specific type of macrophage – and also mentions in
passing the importance of other cells types, such as radial
glial cells and astrocytes, as sources of VEGFs, Wnts and
other signaling molecules that control the shape and func-
tion of the emerging vasculature. Although recent studies
provide compelling evidence for a role of microglia in
shaping the nascent vascular plexuses in the brain and ret-
ina, the molecular mechanisms remain to be elucidated,
and the possibility remains that microglia play a different
role at different locations, for example in the different ret-
inal capillary plexuses. It also remains to be shown what
role, if any, microglia play in vascular homoeostasis in
adult physiological and pathophysiological processes.
Microglial cells become activated in conjunction with
pathological insults and disruption of the blood–brain bar-
rier, where they may play protective or pathogenic roles.
These data are not discussed in the present review, which
is focused on physiological development. However, the
awareness of microglia as a unique CNS cell type with a
distinct ontogeny and equipped with specific developmen-
tal and pathological functions compared to other glial cell
types, has recently increased. Our perspectives on these
cells will undoubtedly grow rapidly in the coming years.Ethical approval
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